MedTrace Logo

Duration of Antibiotic Treatment of Erythema Migrans

NCT00910715 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 306

Last updated 2017-06-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the efficacy of 15-day versus 10-day doxycycline treatment in patients with erythema migrans.

Conditions

  • Erythema Chronicum Migrans

Interventions

DRUG

doxycycline

doxycycline 100 mg bid, 10 days

DRUG

doxycycline

doxycycline 100 mg bid, 15 days

DRUG

placebo

control subjects without a history of Lyme borreliosis

Sponsors & Collaborators

  • University Medical Centre Ljubljana

    lead OTHER

Principal Investigators

  • Franc Strle, MD · UMC Ljubljana

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00910715 on ClinicalTrials.gov